de Heusch et al., 2020 - Google Patents
IL‐9 exerts biological function on antigen‐experienced murine T cells and exacerbates colitis induced by adoptive transferde Heusch et al., 2020
View PDF- Document ID
- 8524940222768378674
- Author
- de Heusch M
- Steenwinckel V
- Cochez P
- Louahed J
- Warnier G
- Lemaire M
- Renauld J
- Dumoutier L
- Publication year
- Publication venue
- European journal of immunology
External Links
Snippet
IL‐9 is involved in various T cell‐dependent inflammatory models including colitis, encepahlitis, and asthma. However, the regulation and specificity of IL‐9 responsiveness by T cells during immune responses remains poorly understood. Here, we addressed this …
- 108010002335 Interleukin-9 0 title abstract description 163
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Goto et al. | Innate lymphoid cells regulate intestinal epithelial cell glycosylation | |
Robinson | The role of the T cell in asthma | |
Symowski et al. | Th2 cell‐derived IL‐4/IL‐13 promote ILC2 accumulation in the lung by ILC2‐intrinsic STAT6 signaling in mice | |
Tu et al. | T cell receptor-regulated TGF-β type I receptor expression determines T cell quiescence and activation | |
Mizoguchi et al. | Regulatory role of mature B cells in a murine model of inflammatory bowel disease | |
Brownlie et al. | Treatment of murine collagen‐induced arthritis by the stress protein BiP via interleukin‐4–producing regulatory T cells: A novel function for an ancient protein | |
Chiba et al. | Mucosal‐associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis | |
Chen et al. | Generation of anergic and regulatory T cells following prolonged exposure to a harmless antigen | |
Faustino et al. | Regulatory T cells migrate to airways via CCR4 and attenuate the severity of airway allergic inflammation | |
Rodríguez-Iturbe et al. | Autoimmunity in the pathogenesis of hypertension | |
Khan et al. | Endogenous pro-and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae | |
Yang et al. | Epstein‐Barr virus‐induced gene 3 negatively regulates IL‐17, IL‐22 and RORγt | |
Raghavan et al. | Absence of CD4+ CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice | |
Leech et al. | Resolution of Der p1-induced allergic airway inflammation is dependent on CD4+ CD25+ Foxp3+ regulatory cells | |
Caspi | Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells | |
Okiyama et al. | Therapeutic effects of interleukin‐6 blockade in a murine model of polymyositis that does not require interleukin‐17A | |
Miescher | Systemic lupus erythematosus | |
Anderson et al. | Testing time-, ignorance-, and danger-based models of tolerance | |
Dumoutier et al. | IL‐22 is produced by γC‐independent CD25+ CCR6+ innate murine spleen cells upon inflammatory stimuli and contributes to LPS‐induced lethality | |
Svensson et al. | γδ T cells contribute to the systemic immunoglobulin E response and local B‐cell reactivity in allergic eosinophilic airway inflammation | |
Cook et al. | Intestinal delivery of proinsulin and IL-10 via Lactococcus lactis combined with low-dose anti-CD3 restores tolerance outside the window of acute type 1 diabetes diagnosis | |
Yi et al. | Long-term remission of diabetes in NOD mice is induced by nondepleting anti-CD4 and anti-CD8 antibodies | |
Tacchini‐Cottier et al. | Notch1 expression on T cells is not required for CD4+ T helper differentiation | |
de Heusch et al. | IL‐9 exerts biological function on antigen‐experienced murine T cells and exacerbates colitis induced by adoptive transfer | |
Thelemann et al. | Absence of nonhematopoietic MHC class II expression protects mice from experimental autoimmune myocarditis |